Piper Jaffray Remains Bullish as Applied Optoelectronics (AAOI) Reports 1Q In-Line with Pre-Announcement

Go back to Piper Jaffray Remains Bullish as Applied Optoelectronics (AAOI) Reports 1Q In-Line with Pre-Announcement

After-Hours Stock Movers 05/09: (STMP) (OPK) (HALO) Higher; (NLNK) (GPS) (BLOX) (RAX) Lower (more...)

May 9, 2016 6:25 PM EDT

NewLink Genetics Corporation (NASDAQ: NLNK) 34.5% LOWER; announced today results of its Phase 3 clinical trial for algenpantucel-L for patients with resected pancreatic cancer. The IMPRESS Phase 3 study of algenpantucel-L for patients with resected pancreatic cancer did not achieve its primary endpoint. Overall survival from time of randomization was 29.3 months for both groups combined. There was no statistically significant difference between the two groups. The median survival was 30.4 months and 27.3 months for the control and study groups, respectively. There was also no statistical difference for long-term survival. Three year survival was... More

Applied Optoelectronics (AAOI) Reports In-Line Q1 EPS

May 9, 2016 4:41 PM EDT

Applied Optoelectronics (NASDAQ: AAOI) reported Q1 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $50.4 million versus the consensus estimate of $51.03 million.

For earnings history and earnings-related data on Applied Optoelectronics (AAOI) click here.

... More